BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16824755)

  • 1. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2.
    Hudson S; Kiankarimi M; Rowbottom MW; Vickers TD; Wu D; Pontillo J; Ching B; Dwight W; Goodfellow VS; Schwarz D; Heise CE; Madan A; Wen J; Ban W; Wang H; Wade WS
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4922-30. PubMed ID: 16824755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1.
    Rowbottom MW; Vickers TD; Dyck B; Grey J; Tamiya J; Zhang M; Kiankarimi M; Wu D; Dwight W; Wade WS; Schwarz D; Heise CE; Madan A; Fisher A; Petroski R; Goodfellow VS
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4450-7. PubMed ID: 16814542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of biarylcarboxamide bis-aminopyrrolidine urea derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
    Rowbottom MW; Vickers TD; Dyck B; Tamiya J; Zhang M; Zhao L; Grey J; Provencal D; Schwarz D; Heise CE; Mistry M; Fisher A; Dong T; Hu T; Saunders J; Goodfellow VS
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3439-45. PubMed ID: 15950467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists.
    Zhang M; Tamiya J; Nguyen L; Rowbottom MW; Dyck B; Vickers TD; Grey J; Schwarz DA; Heise CE; Haelewyn J; Mistry MS; Goodfellow VS
    Bioorg Med Chem Lett; 2007 May; 17(9):2535-9. PubMed ID: 17329101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biaryl ureas as potent and orally efficacious melanin concentrating hormone receptor 1 antagonists for the treatment of obesity.
    Palani A; Shapiro S; McBriar MD; Clader JW; Greenlee WJ; Spar B; Kowalski TJ; Farley C; Cook J; van Heek M; Weig B; O'neill K; Graziano M; Hawes B
    J Med Chem; 2005 Jul; 48(15):4746-9. PubMed ID: 16033253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
    McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
    J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists.
    Huang CQ; Baker T; Schwarz D; Fan J; Heise CE; Zhang M; Goodfellow VS; Markison S; Gogas KR; Chen T; Wang XC; Zhu YF
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3701-6. PubMed ID: 16005225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonists.
    Grey J; Dyck B; Rowbottom MW; Tamiya J; Vickers TD; Zhang M; Zhao L; Heise CE; Schwarz D; Saunders J; Goodfellow VS
    Bioorg Med Chem Lett; 2005 Feb; 15(4):999-1004. PubMed ID: 15686900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
    McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
    J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists.
    Guo T; Gu H; Hobbs DW; Busler DE; Rokosz LL
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1718-21. PubMed ID: 17251014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.
    Galiano S; Ceras J; Cirauqui N; Pérez S; Juanenea L; Rivera G; Aldana I; Monge A
    Bioorg Med Chem; 2007 Jun; 15(11):3896-911. PubMed ID: 17407817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.
    Kim N; Meyers KM; Mendez-Andino JL; Warshakoon NC; Ji W; Wos JA; Colson A; Mitchell MC; Davis JR; Pinney BB; Reizes O; Hu XE
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5445-50. PubMed ID: 16879961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Lim CJ; Kim N; Lee EK; Lee BH; Oh KS; Yoo SE; Yi KY
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2309-12. PubMed ID: 21420863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis.
    Guo T; Hunter RC; Gu H; Rokosz LL; Stauffer TM; Hobbs DW
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3691-5. PubMed ID: 15953726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development.
    Rami HK; Thompson M; Stemp G; Fell S; Jerman JC; Stevens AJ; Smart D; Sargent B; Sanderson D; Randall AD; Gunthorpe MJ; Davis JB
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3287-91. PubMed ID: 16580202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists.
    Ma V; Bannon AW; Baumgartner J; Hale C; Hsieh F; Hulme C; Rorrer K; Salon J; van Staden C; Tempest P
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5066-72. PubMed ID: 16887348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition.
    Fox BM; Natero R; Richard K; Connors R; Roveto PM; Beckmann H; Haller K; Golde J; Xiao SH; Kayser F
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2460-7. PubMed ID: 21414780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicyclo[3.1.0]hexyl urea melanin concentrating hormone (MCH) receptor-1 antagonists: impacting hERG liability via aryl modifications.
    McBriar MD; Guzik H; Shapiro S; Xu R; Paruchova J; Clader JW; O'neill K; Hawes B; Sorota S; Margulis M; Tucker K; Weston DJ; Cox K
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4262-5. PubMed ID: 16753297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonists.
    Palani A; Shapiro S; McBriar MD; Clader JW; Greenlee WJ; O'Neill K; Hawes B
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5234-6. PubMed ID: 16202583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.